NewAmsterdam Pharma Company N.V.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-29.5M | $-29.5M | $24.0K | $1.2M |
| FY2022 | $10.7M | $10.4M | $221.0K | $4.1M |
| FY2023 | $-141.2M | $-141.2M | $24.0K | $24.6M |
| FY2024 | $-158.6M | $-159.2M | $672.0K | $33.6M |
| FY2025 | $-147.8M | $-148.0M | $246.0K | $59.4M |